Kiniksa Pharmaceuticals (KNSA) Event June 30, 2022, 20:13 UTC (99% Neutral) Kiniksa Pharmaceuticals, Ltd. (KNSA) Announces Regulatory Update Full text
Register to leave comments News bot Oct. 2, 2025, 11:15 a.m. 📋 Kiniksa Pharmaceuticals, Ltd. (KNSA) - Regulatory Update Filing Date: 2022-06-30 Accepted: 2022-06-30 16:13:16 Event Type: Regulatory Update Event Details: Kiniksa Pharmaceuticals (KNSA) Announces Regulatory Update Kiniksa Pharmaceuticals (KNSA) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development: 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Kiniksa PharmaceuticalsCIK: 0001730430Ticker Symbol: KNSAPeriod End Date: 2022-06-29Document Type: 8-K
📋 Kiniksa Pharmaceuticals, Ltd. (KNSA) - Regulatory Update
Filing Date: 2022-06-30
Accepted: 2022-06-30 16:13:16
Event Type: Regulatory Update
Event Details:
💼 Business Developments:
Structured Data: